recombinant factor IX chimeric protein (Chimera BioTechnology)

N/A

Report date: 2025/03/19 11:43:02

Base Information

Drug Namerecombinant factor IX chimeric protein (Chimera BioTechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor IX inhibitors
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChimera
China Registration ClassN/A

Develop Information

Active CompaniesChimera
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A